(Q33543091)

27 July 2017

1 reference

title

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease (English)

1 reference

27 July 2017

0 references

1 reference

0 references

1 reference

Jellinger KA

1

1 reference

27 July 2017

publication date

1 February 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

14

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

115-140

1 reference

Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity

27 July 2017

cites work

1 reference

12 December 2020

Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study

1 reference

12 December 2020

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

1 reference

12 December 2020

An in vitro EPR study of the free-radical scavenging actions of the lazaroid antioxidants U-74500A and U-78517F

1 reference

12 December 2020

Free radical-generated neurotoxicity of 6-hydroxydopamine

1 reference

12 December 2020

Involvement of iron in MPP+ toxicity in substantia nigra: protection by desferrioxamine.

1 reference

12 December 2020

Brain iron homeostasis

1 reference

12 December 2020

Iron-dependent enzymes in Parkinson's disease

1 reference

12 December 2020

MRI, brain iron and experimental Parkinson's disease

1 reference

12 December 2020

Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes

1 reference

12 December 2020

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

1 reference

12 December 2020

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

1 reference

12 December 2020

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

1 reference

12 December 2020

EPR investigations of the iron domain in neuromelanin.

1 reference

12 December 2020

Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Dopamine/glutamate interactions in Parkinson's disease

1 reference

12 December 2020

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

1 reference

12 December 2020

Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease

1 reference

12 December 2020

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

1 reference

12 December 2020

The chemical characterization of melanin contained in substantia nigra of human brain

1 reference

12 December 2020

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

12 December 2020

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

1 reference

12 December 2020

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

12 December 2020

Glutathione peroxidase, glial cells and Parkinson's disease

1 reference

12 December 2020

Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy

1 reference

12 December 2020

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

1 reference

12 December 2020

Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals

1 reference

12 December 2020

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I

1 reference

12 December 2020

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

1 reference

12 December 2020

Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease.

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

1 reference

12 December 2020

Oxidative mechanisms in nigral cell death in Parkinson's disease.

1 reference

12 December 2020

In vitro studies of ferritin iron release and neurotoxicity.

1 reference

12 December 2020

Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E.

1 reference

12 December 2020

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

12 December 2020

Lazaroid-enhanced survival of grafted dopamine neurons does not increase target innervation

1 reference

12 December 2020

Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies

1 reference

12 December 2020

Pharmacokinetic optimisation in the treatment of Parkinson's disease

1 reference

12 December 2020

Increasing striatal iron content associated with normal aging

1 reference

12 December 2020

Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Nitric oxide enhances MPP(+) inhibition of complex I.

1 reference

12 December 2020

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.

1 reference

12 December 2020

Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra

1 reference

12 December 2020

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

1 reference

12 December 2020

Inhibitory effects of bromocriptine on phospholipid peroxidation induced by dopa and iron

1 reference

12 December 2020

Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex

1 reference

12 December 2020

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

1 reference

12 December 2020

Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism

1 reference

12 December 2020

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

1 reference

12 December 2020

Iron metabolism and Parkinson's disease

1 reference

12 December 2020

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

1 reference

12 December 2020

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease

1 reference

12 December 2020

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

1 reference

12 December 2020

Neuroprotection by dopamine agonists.

1 reference

12 December 2020

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells

1 reference

12 December 2020

Multi-center study of Parkinson mortality with early versus later dopa treatment

1 reference

12 December 2020

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

12 December 2020

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

1 reference

12 December 2020

Regulation of ferritin and transferrin receptor mRNAs

1 reference

12 December 2020

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

1 reference

12 December 2020

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

Levodopa: is toxicity a myth?

1 reference

12 December 2020

Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers

1 reference

12 December 2020

Widespread peroxynitrite-mediated damage in Alzheimer's disease

1 reference

12 December 2020

New insights into the cause of Parkinson's disease

1 reference

12 December 2020

Early detection of Parkinson's disease. Implications for treatment

1 reference

12 December 2020

Reactive oxygen species and the central nervous system

1 reference

12 December 2020

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

1 reference

12 December 2020

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

1 reference

12 December 2020

MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease

1 reference

12 December 2020

Effect of MPTP and l‐Deprenyl on Antioxidant Enzymes and Lipid Peroxidation Levels in Mouse Brain

1 reference

12 December 2020

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

1 reference

12 December 2020

Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism

1 reference

12 December 2020

Intranigral injected iron progressively reduces striatal dopamine metabolism

1 reference

12 December 2020

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

1 reference

12 December 2020

The effect of deprenyl and levodopa on the progression of Parkinson's disease

1 reference

12 December 2020

The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems

1 reference

12 December 2020

L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro.

1 reference

12 December 2020

Attempts to obtain neuroprotection in Parkinson's disease

1 reference

12 December 2020

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

1 reference

12 December 2020

Neuropathology of movement disorders.

1 reference

12 December 2020

Dietary iron, animal fats, and risk of Parkinson's disease.

1 reference

12 December 2020

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

1 reference

12 December 2020

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

1 reference

12 December 2020

Oxidative damage in the central nervous system: protection by melatonin

1 reference

12 December 2020

Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine

1 reference

12 December 2020

Iron-sulfur clusters as biosensors of oxidants and iron

1 reference

12 December 2020

Glutamatergic drugs in Parkinson's disease

1 reference

12 December 2020

Decreased ferritin levels in brain in Parkinson's disease

1 reference

12 December 2020

Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.

1 reference

12 December 2020

Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease

1 reference

12 December 2020

Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management

1 reference

12 December 2020

Prospects of glutamate antagonists in the therapy of Parkinson's disease

1 reference

12 December 2020

Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: Role of the hydroxamic groups

1 reference

12 December 2020

Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration

1 reference

12 December 2020

Neuromelanin of the human substantia nigra: a mixed-type melanin.

1 reference

12 December 2020

The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.

1 reference

12 December 2020

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

12 December 2020

Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats

1 reference

12 December 2020

The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals

1 reference

12 December 2020

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

1 reference

12 December 2020

Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.

1 reference

12 December 2020

The role of dopamine agonists in early Parkinson's disease

1 reference

12 December 2020

Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.

1 reference

12 December 2020

Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys

1 reference

12 December 2020

Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.

1 reference

12 December 2020

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

12 December 2020

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

1 reference

12 December 2020

Mitochondrial dysfunction in neurodegeneration

1 reference

12 December 2020

The neuroprotective and neuronal rescue effects of (-)-deprenyl

1 reference

12 December 2020

Oxidative stress and antioxidant therapy in Parkinson's disease

1 reference

12 December 2020

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease

1 reference

12 December 2020

Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives

1 reference

12 December 2020

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

1 reference

12 December 2020

Mitochondria, free radicals, and neurodegeneration

1 reference

12 December 2020

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

12 December 2020

Dopamine and iron induce apoptosis in PC12 cells

1 reference

12 December 2020

Glutamate antagonists and Parkinson's disease: a review of clinical data

1 reference

12 December 2020

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

12 December 2020

Superoxide accelerates DNA damage by elevating free-iron levels

1 reference

12 December 2020

Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress.

1 reference

12 December 2020

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

12 December 2020

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

1 reference

12 December 2020

Systemic iron metabolism and mortality from Parkinson's disease.

1 reference

12 December 2020

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain

1 reference

12 December 2020

Transferrin receptors in the parkinsonian midbrain.

1 reference

12 December 2020

Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain

1 reference

12 December 2020

Oxidative stress hypothesis in Alzheimer's disease

1 reference

12 December 2020

(-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition

1 reference

12 December 2020

Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.

1 reference

12 December 2020

Effects of iron complexes on brain calcium homeostasis.

1 reference

12 December 2020

MPTP toxicity in rat striatal slices: dopamine uptake alteration does not appear to be related to lipid peroxidation

1 reference

12 December 2020

Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger

1 reference

12 December 2020

The possible role of iron in the etiopathology of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?

1 reference

12 December 2020

Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin

1 reference

12 December 2020

Drug treatment of Parkinson's disease in the 1990s. Achievements and future possibilities

1 reference

12 December 2020

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice

1 reference

12 December 2020

The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls

1 reference

12 December 2020

Hydroxyl free radical (.OH) formation reflected by salicylate hydroxylation and neuromelanin. In vivo markers for oxidant injury of nigral neurons

1 reference

12 December 2020

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

12 December 2020

Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis

1 reference

12 December 2020

The role of transition metals in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism

1 reference

12 December 2020

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

12 December 2020

A method for the comparative assessment of antioxidants as peroxyl radical scavengers

1 reference

12 December 2020

Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.

1 reference

12 December 2020

The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation

1 reference

12 December 2020

The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease

1 reference

12 December 2020

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

12 December 2020

Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain

1 reference

12 December 2020

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

12 December 2020

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin

1 reference

12 December 2020

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.

1 reference

12 December 2020

Lazaroids improve the survival of grafted rat embryonic dopamine neurons

1 reference

12 December 2020

An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

1 reference

12 December 2020

Neural heme oxygenase-1 expression in idiopathic Parkinson's disease

1 reference

12 December 2020

Neuroprotective therapy for Parkinson's disease

1 reference

12 December 2020

Nonidentical distribution of transferrin and ferric iron in human brain

1 reference

12 December 2020

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity

1 reference

12 December 2020

Understanding cell death in Parkinson's disease

1 reference

12 December 2020

An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease

1 reference

12 December 2020

Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains

1 reference

12 December 2020

Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains

1 reference

12 December 2020

Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.

1 reference

12 December 2020

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

1 reference

12 December 2020

Protein nitration in Parkinson's disease

1 reference

12 December 2020

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

1 reference

12 December 2020

Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice

1 reference

12 December 2020

Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.

1 reference

12 December 2020

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

1 reference

12 December 2020

Dietary antioxidants and Parkinson disease. The Rotterdam Study.

1 reference

12 December 2020

Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity

1 reference

12 December 2020

Isoforms of ferritin have a specific cellular distribution in the brain

1 reference

12 December 2020

Antiparkinsonian therapies and brain mitochondrial complex I activity

1 reference

12 December 2020

Melatonin is protective against MPTP-induced striatal and hippocampal lesions.

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Iron in the Parkinsonian substantia nigra.

1 reference

12 December 2020

L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.

1 reference

12 December 2020

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

1 reference

12 December 2020

Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease

1 reference

12 December 2020

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

1 reference

12 December 2020

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

1 reference

12 December 2020

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

1 reference

12 December 2020

Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures

1 reference

12 December 2020

Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degeneration

1 reference

12 December 2020

Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study

1 reference

12 December 2020

Iron, melanin and dopamine interaction: relevance to Parkinson's disease

1 reference

12 December 2020

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

1 reference

12 December 2020

Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation

1 reference

12 December 2020

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

12 December 2020

Mechanisms of MPTP toxicity

1 reference

12 December 2020

Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones

1 reference

12 December 2020

Mitochondrial toxicity of iron and the protective role of ferritin on dopaminergic PC12 cell line

1 reference

12 December 2020

Antioxidant action of neuromelanin: the mechanism of inhibitory effect on lipid peroxidation

1 reference

12 December 2020

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

12 December 2020

An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease

1 reference

12 December 2020

Oxidative stress: free radical production in neural degeneration.

1 reference

12 December 2020

Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

1 reference

12 December 2020

Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease

1 reference

12 December 2020

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

12 December 2020

Lazaroids. CNS pharmacology and current research

1 reference

12 December 2020

Gallium-transferrin binding in treated and untreated Parkinson's disease

1 reference

12 December 2020

Vitamin E in biological systems.

1 reference

12 December 2020

The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.

1 reference

12 December 2020

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

Metals and free radicals in neurodegeneration

1 reference

12 December 2020

Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders

1 reference

12 December 2020

Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease

1 reference

12 December 2020

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

12 December 2020

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

12 December 2020

Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro

1 reference

12 December 2020

Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites.

1 reference

12 December 2020

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

12 December 2020

Understanding Parkinson's disease.

1 reference

12 December 2020

Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study

1 reference

12 December 2020

Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases

1 reference

12 December 2020

The role of iron in the basal ganglion

1 reference

12 December 2020

Does levodopa therapy delay death in Parkinson's disease? A review of the evidence

1 reference

12 December 2020

Neuronal vulnerability in Parkinson's disease.

1 reference

12 December 2020

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1 reference

12 December 2020

The rationale for the use of dopamine agonists in Parkinson's disease

1 reference

12 December 2020

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1 reference

12 December 2020

Altered systemic iron metabolism in Parkinson's disease

1 reference

12 December 2020

The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders

1 reference

12 December 2020

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

12 December 2020

Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra

1 reference

12 December 2020

Antioxidant defense of the brain: a role for astrocytes

1 reference

12 December 2020

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

12 December 2020

Dopamine agonists in Parkinson's disease: a look at apomorphine

1 reference

12 December 2020

Oxidation of deseferrioxamine to nitroxide free radical by activated human neutrophils

1 reference

12 December 2020

Degeneration of dopaminergic neurons and free radicals. Possible participation of levodopa

1 reference

12 December 2020

Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism

1 reference

12 December 2020

[The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate]

1 reference

12 December 2020

Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion.

1 reference

12 December 2020

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

1 reference

12 December 2020

Is complex II involved in the inhibition of mitochondrial respiration by N-methyl-4-phenylpyridinium cation (MMP+) and N-methyl-beta-carbolines?

1 reference

12 December 2020

Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy

1 reference

12 December 2020

Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra

1 reference

12 December 2020

Pharmacology of lazaroids and brain energy metabolism: a review

1 reference

12 December 2020

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

12 December 2020

Current status of iron chelation therapy with deferoxamine

1 reference

12 December 2020

Diet, body size and micronutrient status in Parkinson's disease

1 reference

12 December 2020

Peripheral iron metabolism in patients with Parkinson's disease

1 reference

12 December 2020

Controversies about iron in parkinsonian and control substantia nigra.

1 reference

12 December 2020

Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat

1 reference

12 December 2020

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

12 December 2020

The role of glutathione in dopaminergic neuronal survival.

1 reference

12 December 2020

Mortality associated with early and late levodopa therapy initiation in Parkinson's disease

1 reference

12 December 2020

The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis

1 reference

12 December 2020

10.2165/00002512-199914020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1046738317

0 references

1 reference